Gland Pharma appoints Shyamakant Giri as CEO
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Giri is currently the President (India Business & Emerging Markets) of Amneal Pharmaceuticals
Aims to achieve CDMO sales of US$ 400 million by 2028
He holds a Master’s in Management from the National University of Singapore
The inspection concluded with the issuance of a form 483 with five observations
This initiative aims to raise awareness about the importance of monitoring blood sugar levels before indulging in sweets
The company will now seek final approval from NCLT, Mumbai Bench, and upon its receipt, OneSource will proceed to seek listing approvals from the BSE and NSE
MedTech Mitra initiative aims to empower MedTech innovators and advance healthcare solutions
Ami informs that PMDA Japan has issued Inspection Result Report declaring the Sachin facility as a Good Manufacturing Practices (GMP) compliant.
Subscribe To Our Newsletter & Stay Updated